Funding for this research was provided by:
Otsuka Pharmaceutical Factory
Otsuka America Pharmaceutical
Received: 20 March 2022
Accepted: 14 September 2022
First Online: 27 October 2022
: The study protocol was approved by the Ethics Committees of the Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences (No. 2108-041) and the Kurume University Graduate School of Medicine (No. 21139) and registered at the University Hospital Medical Information Network Clinical Trial Registry (UMIN000044962). Informed consent was not required, because all personal information used in this study was anonymized.
: Not applicable.
: Dr. Takagi and Dr. Murotani report grants from Otsuka Pharmaceutical Factory, Inc. during the conduct of the study. Satoru Kamoshita and Akiyoshi Kuroda are employees of Otsuka Pharmaceutical Factory, Inc. and hold stocks of Otsuka Holdings Co., Ltd.